Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.
To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).
Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).
Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Kihara A | [Multifunctional sphingolipid, sphingosine (long-chain base) 1-phosphate: physiological role, metabolism, and intracellular dynamics]. | 2006 | Seikagaku | pmid:16986722 |
Birgbauer E and Chun J | New developments in the biological functions of lysophospholipids. | 2006 | Cell. Mol. Life Sci. | pmid:16988788 |
Ryu J et al. | Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. | 2006 | EMBO J. | pmid:17124500 |
Jin YX et al. | Sphingosine kinase assay system with fluorescent detection in high performance liquid chromatography. | 2006 | Arch. Pharm. Res. | pmid:17146975 |
Taha TA et al. | A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death. | 2006 | Biochim. Biophys. Acta | pmid:17161984 |
Fisher KE et al. | Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling. | 2006 | Mol. Cancer | pmid:17156449 |
Huwiler A and Pfeilschifter J | Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy. | 2006 | Curr. Pharm. Des. | pmid:17168766 |
Pan S et al. | A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model. | 2006 | Chem. Biol. | pmid:17114004 |
Malaplate-Armand C et al. | Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway. | 2006 | Neurobiol. Dis. | pmid:16626961 |
Hiraga Y et al. | Changes in S1P1 and S1P2 expression during embryonal development and primitive endoderm differentiation of F9 cells. | 2006 | Biochem. Biophys. Res. Commun. | pmid:16631609 |
French KJ et al. | Antitumor activity of sphingosine kinase inhibitors. | 2006 | J. Pharmacol. Exp. Ther. | pmid:16632640 |
Milstien S and Spiegel S | Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics. | 2006 | Cancer Cell | pmid:16530698 |
Visentin B et al. | Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. | 2006 | Cancer Cell | pmid:16530706 |
Scherer EQ et al. | Sphingosine-1-phosphate modulates spiral modiolar artery tone: A potential role in vascular-based inner ear pathologies? | 2006 | Cardiovasc. Res. | pmid:16533504 |
Rouach N et al. | S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK. | 2006 | Eur. J. Neurosci. | pmid:16553609 |
Brizuela L et al. | Sphingosine 1-phosphate: a novel stimulator of aldosterone secretion. | 2006 | J. Lipid Res. | pmid:16554657 |
Chatterjee S et al. | The role of the phospholipid sphingomyelin in heart disease. | 2006 | Curr Opin Investig Drugs | pmid:16555682 |
Zeidan YH et al. | Acid ceramidase but not acid sphingomyelinase is required for tumor necrosis factor-{alpha}-induced PGE2 production. | 2006 | J. Biol. Chem. | pmid:16803890 |
Dindo D et al. | Cationic long-chain ceramide LCL-30 induces cell death by mitochondrial targeting in SW403 cells. | 2006 | Mol. Cancer Ther. | pmid:16818511 |
Durand CA et al. | The Rap GTPases mediate CXCL13- and sphingosine1-phosphate-induced chemotaxis, adhesion, and Pyk2 tyrosine phosphorylation in B lymphocytes. | 2006 | Eur. J. Immunol. | pmid:16821235 |
Giussani P et al. | Sphingosine-1-phosphate phosphohydrolase regulates endoplasmic reticulum-to-golgi trafficking of ceramide. | 2006 | Mol. Cell. Biol. | pmid:16782891 |
Sanna MG et al. | Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. | 2006 | Nat. Chem. Biol. | pmid:16829954 |
Veracini L et al. | Two distinct pools of Src family tyrosine kinases regulate PDGF-induced DNA synthesis and actin dorsal ruffles. | 2006 | J. Cell. Sci. | pmid:16787943 |
Hemmings DG et al. | Sphingosine-1-phosphate acts via rho-associated kinase and nitric oxide to regulate human placental vascular tone. | 2006 | Biol. Reprod. | pmid:16162874 |
Yamashita H et al. | Sphingosine 1-phosphate receptor expression profile in human gastric cancer cells: differential regulation on the migration and proliferation. | 2006 | J. Surg. Res. | pmid:16183075 |
Sparkman L et al. | Ceramide decreases surfactant protein B gene expression via downregulation of TTF-1 DNA binding activity. | 2006 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:16183668 |
Ozbay T et al. | Cyclic adenosine 5'-monophosphate-dependent sphingosine-1-phosphate biosynthesis induces human CYP17 gene transcription by activating cleavage of sterol regulatory element binding protein 1. | 2006 | Endocrinology | pmid:16306078 |
Park KS et al. | Lysophosphatidylserine stimulates L2071 mouse fibroblast chemotactic migration via a process involving pertussis toxin-sensitive trimeric G-proteins. | 2006 | Mol. Pharmacol. | pmid:16368894 |
Kim MY et al. | Sphingosine-1-phosphate activates BKCa channels independently of G protein-coupled receptor in human endothelial cells. | 2006 | Am. J. Physiol., Cell Physiol. | pmid:16267108 |
di Villa Bianca Rd et al. | Sphingosine 1-phosphate induces endothelial nitric-oxide synthase activation through phosphorylation in human corpus cavernosum. | 2006 | J. Pharmacol. Exp. Ther. | pmid:16234413 |
Bu S et al. | Dihydrosphingosine 1-phosphate stimulates MMP1 gene expression via activation of ERK1/2-Ets1 pathway in human fibroblasts. | 2006 | FASEB J. | pmid:16278291 |
Inniss K and Moore H | Mediation of apoptosis and proliferation of human embryonic stem cells by sphingosine-1-phosphate. | 2006 | Stem Cells Dev. | pmid:17253942 |
Matsuyuki H et al. | Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P. | 2006 | Cell. Mol. Immunol. | pmid:17257496 |
Kang JS et al. | Glabridin suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking sphingosine kinase pathway: implications of Akt, extracellular signal-regulated kinase, and nuclear factor-kappaB/Rel signaling pathways. | 2006 | Mol. Pharmacol. | pmid:16354764 |
Donati C and Bruni P | Sphingosine 1-phosphate regulates cytoskeleton dynamics: implications in its biological response. | 2006 | Biochim. Biophys. Acta | pmid:16890187 |
Thompson B et al. | Protein kinase Calpha and sphingosine 1-phosphate-dependent signaling in endothelial cell. | 2006 | Prostaglandins Other Lipid Mediat. | pmid:16846783 |
Long JS et al. | The functional PDGFbeta receptor-S1P1 receptor signaling complex is involved in regulating migration of mouse embryonic fibroblasts in response to platelet derived growth factor. | 2006 | Prostaglandins Other Lipid Mediat. | pmid:16846788 |
Nagata Y et al. | Entry of muscle satellite cells into the cell cycle requires sphingolipid signaling. | 2006 | J. Cell Biol. | pmid:16847102 |
Xu R et al. | Golgi alkaline ceramidase regulates cell proliferation and survival by controlling levels of sphingosine and S1P. | 2006 | FASEB J. | pmid:16940153 |
Schultz C | Lipid-induced phenotypes. | 2006 | Nat. Chem. Biol. | pmid:16850012 |
Brinkmann V and Baumruker T | Pulmonary and vascular pharmacology of sphingosine 1-phosphate. | 2006 | Curr Opin Pharmacol | pmid:16563863 |
Hemmings DG | Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine. | 2006 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:16570136 |
Choueiri TK et al. | Phenoxodiol: isoflavone analog with antineoplastic activity. | 2006 | Curr Oncol Rep | pmid:16507219 |
Naetzker S et al. | Activation of p38 mitogen-activated protein kinase and partial reactivation of the cell cycle by cis-4-methylsphingosine direct postmitotic neurons towards apoptosis. | 2006 | Genes Cells | pmid:16483315 |
Jurisicova A et al. | Molecular requirements for doxorubicin-mediated death in murine oocytes. | 2006 | Cell Death Differ. | pmid:16439991 |
Bassi R et al. | Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors. | 2006 | Glia | pmid:16470810 |
Yatomi Y | Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases. | 2006 | Curr. Pharm. Des. | pmid:16472149 |
Kurobe H et al. | CCR7-dependent cortex-to-medulla migration of positively selected thymocytes is essential for establishing central tolerance. | 2006 | Immunity | pmid:16473829 |
Kitano M et al. | Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. | 2006 | Arthritis Rheum. | pmid:16508938 |
Hsieh HL et al. | Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells. | 2006 | J. Cell. Physiol. | pmid:16508949 |